TYRA (STOCKS)
Tyra Biosciences, Inc. Common Stock
$29.070000
+0.860000 (+3.05%)
Prev close: $28.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Todd J. Harris
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,729.70M
- Employees
- 60
- P/E (TTM)
- -13.37
- P/B (TTM)
- 4.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
10
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.64 | $-0.60 | -0.0356 | -5.89% |
|
Dec 2025 (Q4)
|
$-0.57 | $-0.54 | -0.0313 | -5.81% |
|
Sep 2025 (Q3)
|
$-0.50 | $-0.51 | +0.0075 | +1.48% |
|
Jun 2025 (Q2)
|
$-0.47 | $-0.54 | +0.0693 | +12.85% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $11.81M |
| Operating Expenses | $142.91M |
| Research and Development | $111.43M |
| Other Operating Expenses | $31.48M |
| Operating Income/Loss | -$142.91M |
| Income/Loss From Continuing Operations After Tax | -$131.11M |
| Income/Loss From Continuing Operations Before Tax | -$131.11M |
| Net Income/Loss | -$131.11M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$131.11M |
| Net Income/Loss Available To Common Stockholders, Basic | -$131.11M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.17 |
| Diluted Earnings Per Share | -$2.17 |
| Basic Average Shares | 181,045,929 |
| Diluted Average Shares | 181,045,929 |
| Assets | $412.04M |
| Current Assets | $394.61M |
| Noncurrent Assets | $17.43M |
| Fixed Assets | $1.22M |
| Other Non-current Assets | $16.21M |
| Liabilities | $24.47M |
| Current Liabilities | $19.26M |
| Accounts Payable | $3.64M |
| Other Current Liabilities | $15.61M |
| Noncurrent Liabilities | $5.21M |
| Equity | $387.58M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $387.58M |
| Liabilities And Equity | $412.04M |
| Net Cash Flow From Operating Activities | -$102.26M |
| Net Cash Flow From Operating Activities, Continuing | -$102.26M |
| Net Cash Flow From Investing Activities | -$79.81M |
| Net Cash Flow From Investing Activities, Continuing | -$79.81M |
| Net Cash Flow From Financing Activities | $166.30M |
| Net Cash Flow From Financing Activities, Continuing | $166.30M |
| Net Cash Flow | -$15.77M |
| Net Cash Flow, Continuing | -$15.77M |
| Comprehensive Income/Loss | -$131.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$131.69M |
| Other Comprehensive Income/Loss | -$103.34M |